Antidepressant drug interactions: evidence and clinical significance

ReviewFree Access Antidepressant drug interactions: evidence and clinical significance Stephen Bleakley MRPharmS, MSc, FCMHP, Stephen Bleakley MRPharmS, MSc, FCMHPSearch for more papers by this author Stephen Bleakley MRPharmS, MSc, FCMHP, Stephen Bleakley MRPharmS, MSc, FCMHPSearch for more papers by this author First published: 08 June 2016 https://doi.org/10.1002/pnp.429Citations: 20AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Abstract Antidepressants are widely used in the general population, primarily to treat depression but also commonly in conditions such as anxiety disorders and neuropathic pain. This article considers the significant pharmacodynamic and pharmacokinetic drug interactions of different antidepressants, whilst remembering that individual patient characteristics are of utmost importance in the prescribing decision. Citing Literature Volume20, Issue3May/June 2016Pages 21-27 RelatedInformation